PatientsVille.com Logo

PatientsVille

Transamin Side Effects

Common Transamin Side Effects


The most commonly reported Transamin side effects (click to view or check a box to report):

Pneumonia (4)
Pyrexia (3)
Septic Shock (2)
Renal Failure Acute (2)
Weight Increased (1)
Rash Erythematous (1)
Uterine Haemorrhage (1)
Scab (1)
Respiratory Failure (1)
Pleural Effusion (1)
Throat Irritation (1)
Tongue Coated (1)
Hypokalaemia (1)
Mucosal Erosion (1)
Overdose (1)
Malaise (1)
Lymphadenopathy (1)
Hepatic Function Abnormal (1)
Leukocytosis (1)
Hepatic Cirrhosis (1)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Transamin Side Effects Reported to FDA

The following Transamin reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Transamin on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Renal Failure Acute, Cardiac Failure Congestive, Septic Shock, Pneumonia
This is a report of a 69-year-old male patient (weight: NA) from TAIWAN, PROVINCE OF CHINA, suffering from the following symptoms/conditions: NA, who was treated with Transamine Cap (dosage: 250 Mg, 4x/day (q6h), start time: Mar 01, 2012), combined with:
  • Solu-cortef (100 Mg, 3x/day (q8h))
  • Meropenem (1 G, 2x/day (q12h))
  • Nutrase (100 Mg, 1x/day (qd))
  • Acetylcysteine (200 Mg, 4x/day (qid))
  • Unasyn (1.5 G, 2x/day (q12h))
  • Sinemet (125 Mg, 3x/day (tid))
  • Sennapur (25 Mg, 1x/day (hs))
  • Diflucan (200 Mg, 1x/day (qd))
and developed a serious reaction and side effect(s). The consumer presented with:
  • Renal Failure Acute
  • Cardiac Failure Congestive
  • Septic Shock
  • Pneumonia
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Transamine Cap treatment in male patients, resulting in renal failure acute side effect. The patient was hospitalized.

Depression
This report suggests a potential Transamine Cap Depression side effect(s) that can have serious consequences. A 62-year-old male patient (weight: NA) from JAPAN was diagnosed with the following symptoms/conditions: NA and used Transamine Cap (dosage: NA) starting Mar 06, 2012. Soon after starting Transamine Cap the patient began experiencing various side effects, including:
  • Depression
Drugs used concurrently:
  • Atropine Sulfate Hydrate
  • Cefazolin Sodium
  • Ribavirin
  • Peginterferon Alfa-2b
  • Ribavirin
  • Adona
  • Atarax
  • Telavic (telaprevir)
Although Transamine Cap demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as depression, may still occur.

Dysmenorrhoea, Agranulocytosis
This Dysmenorrhoea, Agranulocytosis problem was reported by a physician from JAPAN. A female patient (weight: NA) was diagnosed with the following symptoms/conditions: influenza. On Feb 11, 2012 this consumer started treatment with Transamine Cap (dosage: Dosage Is Uncertain). The following drugs were being taken at the same time:
  • Acetaminophen (Dosage Is Uncertain)
  • Tamiflu
  • Mao-to (Dosage Is Uncertain)
  • Hangekobokuto (Dosage Is Uncertain.)
When commencing Transamine Cap, the patient experienced the following unwanted symptoms/side effects:
  • Dysmenorrhoea
  • Agranulocytosis
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as dysmenorrhoea, may become evident only after a product is in use by the general population.

Pleural Effusion, Hypokalaemia, Pneumonia
This is a report of a male patient (weight: NA) from JAPAN. The patient developed the following symptoms/conditions: NA and was treated with Transamine Cap (dosage: NA) starting Sep 01, 2011. Concurrently used drugs:
  • Garenoxacin Mesylate
  • Itraconazole
  • Zithromax
  • Garenoxacin Mesylate
  • Zithromax
  • Adona
  • Itraconazole
  • Garenoxacin Mesylate
Soon after that, the consumer experienced the following side effects:
  • Pleural Effusion
  • Hypokalaemia
  • Pneumonia
This opens a possibility that Transamine Cap treatment could cause the above reactions, including pleural effusion, and some male subjects may be more susceptible.


Renal Failure, Hepatic Cirrhosis
A female patient (weight: NA) from JAPAN with the following symptoms/conditions: abscess sweat gland started Transamine Cap treatment (dosage: 1 Df, Tid) on Mar 02, 2012. Soon after starting Transamine Cap treatment, the subject experienced various side effects, including:
  • Renal Failure
  • Hepatic Cirrhosis
Concurrently used drugs:
  • Gorei-san (2.5 G, Tid)
  • Lamivudine (epivir Hbv) (1 Df, Qd)
  • Rabeprazole Sodium (1 Df, Qd)
  • Promacta (1 Df, Bid)
  • Gasmotin (1 Df, Tid)
  • Zolpidem (1 Df, Qd)
  • Hepsera (1 Df, Qd)
  • Aminoleban En (50 G, Tid)
This finding indicates that some female patients could be more vulnerable to Transamine Cap.

Pyrexia, Decreased Appetite, Diarrhoea, Gastroenteritis
A 75-year-old male patient from JAPAN (weight: NA) experienced symptoms, such as: mycobacterium avium complex infection and was treated with Transamine Cap(dosage: 250 Mg, 3x/day). The treatment was initiated on Jul 09, 2009. After that a consumer reported the following side effect(s):
  • Pyrexia
  • Decreased Appetite
  • Diarrhoea
  • Gastroenteritis
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Transamine Cap efficacy:
  • Lendormin (0.25 Mg, 1x/day)
  • Rifabutin (300 Mg, 1x/day)
  • Rifabutin (150 Mg, 1x/day)
  • Streptomycin Sulfate (750 Mg, 3x/week)
  • Clarithromycin (600 Mg, 1x/day)
  • Adona (30 Mg, 3x/day)
  • Rifabutin (150 Mg, 1x/day)
  • Rifabutin (150 Mg, 2x/day)
The patient was hospitalized.

Pyrexia, Weight Increased, Lymphadenopathy, Rash Erythematous, Leukocytosis, Rash Maculo-papular, Malaise, Hepatic Function Abnormal
In this report, Transamin was administered for the following condition: oropharyngeal pain.A 63-year-old female consumer from JAPAN (weight: NA) started Transamin treatment (dosage: Unk) on Jan 01, 2010.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Pyrexia
  • Weight Increased
  • Lymphadenopathy
  • Rash Erythematous
  • Leukocytosis
  • Rash Maculo-papular
  • Malaise
  • Hepatic Function Abnormal
A possible interaction with other drugs could have contributed to this reaction:
  • Asverin (Unk)
  • Tegretol (Unk)
  • Marzulene (Unk)
  • Garenoxacin Mesylate (Unk)
The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Transamin treatment could be related to the listed above side effect(s).

Uterine Haemorrhage
This is a report of the following Transamin side effect(s):
  • Uterine Haemorrhage
A 50-year-old female patient from JAPAN (weight: NA) presented with the following condition: NA and received a treatment with Transamin (dosage: NA) starting: Jul 14, 2011.The following concurrently used drugs could have generated interactions:
  • Fesin
  • Leuprolide Acetate
  • Adona
The patient was hospitalized.This report suggests that a Transamin treatment could be associated with the listed above side effect(s).

Septic Shock, Haemorrhagic Infarction
This Transamin report was submitted by a 76-year-old male consumer from JAPAN (weight: NA). The patient was diagnosed with: haemostasis,acidosis,infection,hypertension,prophylaxis against gastrointestinal ulcer,brain oedema and Transamin was administered (dosage: 1 G, Unk) starting: Feb 15, 2011. The consumer developed a set of symptoms:
  • Septic Shock
  • Haemorrhagic Infarction
Other drugs used simultaneously:
  • Sodium Bicarbonate (250 Ml, Unk)
  • Sandoglobulin (5 G, Unk)
  • Nicardipine Hcl (120 Mg, Unk)
  • Famotidine (40 Mg, Unk)
  • Glyceol (400 Ml, Unk)
  • Zosyn (13.5 G, Unk)
  • Edaravone (30 Mg, 2x/day)
  • Nitrazepam (72 Mg, Unk)
Those unexpected symptoms could be linked to a Transamin treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Gastrointestinal Haemorrhage, Pneumonia
This is a report of a possible correlation between Transamin use and the following symptoms/side effect(s):
  • Gastrointestinal Haemorrhage
  • Pneumonia
which could contribute to an assessment of Transamin risk profile.A 84-year-old male consumer from JAPAN (weight: NA) was suffering from NA and was treated with Transamin (dosage: Daily Dose 2 G) starting Dec 30, 2010.Other concurrent medications:
  • Ciprofloxacin (300 Mg, Bid)
  • Aminoacetic Acid/cysteine/glycyrrhizic Acid (Daily Dose 40 Ml)
  • Multi-vitamin (Daily Dose 40 Ml)
  • Adona (Daily Dose 100 Mg)


Cardiac Failure
A 87-year-old female patient from JAPAN (weight: NA) presented with the following symptoms: atypical mycobacterial infection and after a treatment with Transamin (dosage: 750 Mg) experienced the following side effect(s):
  • Cardiac Failure
The treatment was started on Mar 17, 2010. Transamin was used in combination with the following drugs:
  • Clarithromycin
  • Adona (30 Mg)
The patient was hospitalized.This report could alert potential Transamin consumers.

Cardio-respiratory Arrest, Respiratory Failure, Overdose, Gamma-glutamyltransferase Increased, Pyrexia, Renal Failure Acute, Haematuria
In this report, a male patient from JAPAN (weight: NA) was affected by a possible Transamin side effect.The patient was diagnosed with haematuria. After a treatment with Transamin (dosage: NA, start date: NS), the patient experienced the following side effect(s):
  • Cardio-respiratory Arrest
  • Respiratory Failure
  • Overdose
  • Gamma-glutamyltransferase Increased
  • Pyrexia
  • Renal Failure Acute
  • Haematuria
The following simultaneously used drugs could have led to this reaction:
  • Adona (3 Df, 3 In 1 Day)
  • Maglax (3 Df, 3 In 1 Day)
  • Tamsulosin Hcl (1 Df, 1 In 1 Day)
  • Cravit
  • Nicergoline (3 Df, 3 In 1 Day)
  • Diovan
  • Aricept
  • Topharmin (1 Df, 1 In 1day)
The findings here stress that side effects should be taken into consideration when evaluating a Transamin treatment.

Pneumonia
This is a report of a 84-year-old male patient from JAPAN (weight: NA), who used Transamin (dosage: Daily Dose 2 G) for a treatment of NA. After starting a treatment on Dec 30, 2010, the patient experienced the following side effect(s):
  • Pneumonia
The following drugs could possibly have interacted with the Transamin treatment
  • Ciprofloxacin Betain (300 Mg, Bid)
  • Multi-vitamins (Daily Dose 40 Ml)
  • Adona (Daily Dose 100 Mg)
Taken together, these observations suggest that a Transamin treatment could be related to side effect(s), such as Pneumonia.

Throat Irritation, Scab, Dry Eye, Erythema, Cheilitis, Mucosal Erosion, Diphtheria, Tongue Coated, Blepharosynechia
This throat irritation side effect was reported by a physician from JAPAN. A 43-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA. The patient was prescribed Transamin (dosage: 750mg Per Day), which was started on Nov 26, 2009. Concurrently used drugs:
  • Unasyn
When starting to take Transamin the consumer reported the following symptoms:
  • Throat Irritation
  • Scab
  • Dry Eye
  • Erythema
  • Cheilitis
  • Mucosal Erosion
  • Diphtheria
  • Tongue Coated
  • Blepharosynechia
The patient was hospitalized. These side effects may potentially be related to Transamin.

Blood Glucose Increased, Eczema
This is a Transamin side effect report of a male patient (weight:NA) from JAPAN, suffering from the following symptoms/conditions: NA, who was treated with Transamin (dosage:500 Mg, start time: Jun 04, 2010), combined with:
  • Sorafenib Tosilate (800 Mg)
  • Actos (15 Mg, Unk)
  • Novorapid (18 Df)
  • Interferon Alfa (5000000 Df, Unk)
  • Afinitor (10 Mg, Daily)
  • Afinitor (10 Mg, Daily)
  • Teceleukin (700000 Df, Unk)
  • Afinitor (5 Mg, Daily)
, and developed a serious reaction and a blood glucose increased side effect. The patient presented with:
  • Blood Glucose Increased
  • Eczema
which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Transamin treatment in male patients suffering from NA, resulting in blood glucose increased.



Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Transamin Side Effects

    Did You Have a Transamin Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Transamin for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Transamin Safety Alerts, Active Ingredients, Usage Information

    More About Transamin

    Side Effects reported to FDA: 15

    Transamin safety alerts: No

    Reported deaths: 4

    Reported hospitalizations: 4

    Latest Transamin clinical trials